Evidence Synthesis
MAXHEALTH's 62.52% accelerated to its highest quarterly value, up from 19.73%.
This represents a significant improvement over its previous reading.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 23 Aug 2026, 00:02
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
MAXHEALTH's 62.52% accelerated to its highest quarterly value, up from 19.73%.
This represents a significant improvement over its previous reading.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 62.52 % | 19.73 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 19.73 % | 16.72 | ▲ |
| REVENUE_GROWTH_YOY | 16.7 % | 4.8 | ▲ |
| EPS_ACTUAL | 5.02 INR | 3.499 | ▲ |
| EPS_SURPRISE_PERCENT | 0.21 % | -0.087 | ▲ |
| PRICE_CHANGE_PERCENT | 0.21 % | — | - |
| DAILY_VOLUME | 12,36,731 shares | 23,86,970 | ▼ |
| CLOSE_PRICE | 1,000 INR | 997.9 | ▲ |
| NEWS_SENTIMENT_SCORE | 0.61 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 8 count | 13 | ▼ |
| TARGET_PRICE_PREMIUM | 16.95 % | — | - |